<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α Expression in Invasive Ductal Breast Cancer Patients and Correlations with Prognosis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>823</FirstPage>
			<LastPage>829</LastPage>
			<ELocationID EIdType="pii">30509</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>The aim of the present study was to investigate the expression of the transcription factor Ki-67, ER, PR,Her2/neu, p21, EGFR, and TOP II-α in the tumor tissue of patients with invasive ductal carcinoma(IDC); inaddition, we examined correlations between these markers. Two hundred and sixteen IDC patients, who werenot previously been treated with chemo- or radiotherapy, were included in the study. All tumors were grade I-III.Expression of molecular markers was determined by immunohistochemical analysis on paraffin-embedded tissuesections. Follow-up data were collected for 3 months to 10 years and analyzed for tumor recurrence, survival time,and prognostic risk factors. We determined Ki-67 expression correlates with the expression of ER, PR, HER-2,EGFR, and TOP-α, as well as lymph node involvement, high tumor grade, lymphovascular invasion, high tumorstage, and high TNM stage in IDC. Positive Ki-67 expression was a risk factor for rapid tumor recurrence andmay help tumor progression, leading to poor prognosis in IDC. Ki-67 was directly correlated with EGFR, TOPII-α, lymph node involvement, high tumor grade, lymphovascular invasion, high tumor stage, and high TNMstage in the hormone receptor subtypes of breast cancer. In triple negative breast cancer, Ki-67 correlated withTOP II-α. Expression of Ki-67 correlated with that of ER, PR, HER-2, EGFR, TOP II-α, and p21. In addition,the biomarker Ki-67 has a role as a prognostic factor and indicates a poor prognosis in IDC.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Ki-67</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">invasive ductal breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30509_a6e05a6571ef8b4eba9a2278b4f2297a.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
